Home
About
Leadership
Medical Advisory Board (AC5)
Scientific & Clinical Advisors
Corporate Mission
Products
Ordering Information
Intellectual Property
AC5 Advanced Wound System
Technology
Platform
Preclinical Data
Clinical Data
Pipeline
Pipeline Opportunity
Investors
Investor Relations
IR Overview
News
Press Releases
IR Calendar
Presentations
Interviews
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Governance Documents
Contact
Home
Investors
News
Press Releases
Investors
Overview
News
Press Releases
IR Calendar
Presentations
Interviews
Stock Data
SEC Filings
Corporate Governance
Press Releases
All News
By Year:
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
01/6/22
Clinical Evaluation Finds Arch Therapeutics’ AC5® Advanced Wound System Effective in Healing Complex Chronic Wounds in Patients with Previously Unsuccessful Treatments and Significant Comorbidities
01/4/22
Arch Therapeutics Announces Appointment of Guy Fish to the Board
12/13/21
Arch Therapeutics Granted Federal Supply Schedule and General Supply Administration Contracts for AC5® Advanced Wound System
12/1/21
Arch Therapeutics Adds Key Opinion Leader Interview on Diabetic Foot Ulcers to the Experts in Wound Care Program
11/1/21
Arch Therapeutics Presents AC5® Advanced Wound System During Innovation Spotlight at 2021 Symposium on Advanced Wound Care (SAWC)
10/25/21
Arch Therapeutics to Present AC5 Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC) Fall
10/18/21
Arch Therapeutics Launches Experts in Wound Care Program
10/13/21
Arch Therapeutics Provides Corporate Update
10/6/21
Arch Therapeutics to Present at the LD Micro Main Event
10/4/21
Arch Therapeutics Launches Coverage and Reimbursement Pilot
<< Previous
1
2
3
4
5
6
7
8
9
10
...14
Next >>
Show All